RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Brazil: Advisory Council Discusses New ANVISA

Brazil: Advisory Council Discusses New ANVISA

Posted 23 April 2012 | By Ansis Helmanis

ANVISA's Advisory Council-a group including representatives of the National Confederations of Industry (CNI), Commerce (CNC) and Health (CNS) and councils that represent the health secretaries of Brazilian states and municipalities-came together to discuss the new structure of the Brazilian regulatory agency at its 38th meeting on 18 April 2012.

The restructuring also resulted in the development of a Strategic Plan for the agency for the coming years, which the Council noted should include evaluating the possibility of creating quality indicators for orthotics and prosthetics.

The Advisory Council Chair, Marcia Amaral, Executive Secretary of the Ministry of Health, said the next meeting of the Council, scheduled for June will focus on the agency's Strategic Planning.


Read more:

ANVISA - Advisory Council

More Breaking News from RegLink

 

© 2022 Regulatory Affairs Professionals Society.